Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)

Company
GlaxoSmithKline (Ireland) Ltd
Active Ingredient
Dosage Form
Powder and suspension for suspension for injection
Legal Category
A - prescription, may not be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/23/1740/001 RSVPreF31 antigen2,3 120 micrograms J07BX05 Powder and suspension for suspension for injection
EU/1/23/1740/002 RSVPreF31 antigen2,3 120 micrograms J07BX05 Powder and suspension for suspension for injection
Licence number
EU/1/23/1740/001
Strength
RSVPreF31 antigen2,3 120 micrograms
ATC Code
J07BX05
Dosage Form
Powder and suspension for suspension for injection
Licence number
EU/1/23/1740/002
Strength
RSVPreF31 antigen2,3 120 micrograms
ATC Code
J07BX05
Dosage Form
Powder and suspension for suspension for injection

GlaxoSmithKline (Ireland) Ltd

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland, D24 Dublin

Telephone
+3531800244255